News

RSSL Wins Employer of the Year Award

Reading Scientific Services Ltd (RSSL) has been named Employer of the Year 2021 at the Thames Valley Awards, in recognition of its outstanding dedication to staff development, engagement and wellbeing.

RSSL successfully demonstrated its commitment to employees through a diverse, inclusive and creative programme of initiatives. Importantly, the organisation also showed its ability to adapt to the restrictions and pressures placed on staff during the pandemic; moving key aspects online and boosting other areas of support where they were needed most.

RSSL Wins Business of the Year Award

Reading Scientific Services Ltd (RSSL) has been named Business of the Year 2021 at the Thames Valley Awards, with the judges praising its forward-thinking approach and strong commercial performance.

May eNews

Click here to view the May 2021 edition of eNews.

Inivata to be Acquired by NeoGenomics

Research Triangle Park, NC, USA and Cambridge, UK, 5 May 2021 -- Inivata, a leader in liquid biopsy, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has agreed to acquire Inivata. The acquisition follows a $25 million minority equity investment by NeoGenomics in Inivata in May 2020, at which time NeoGenomics was granted a fixed price option to purchase the remainder of Inivata for $390 million.

Mogrify completes Series A financing totaling $33 million USD

Cambridge, UK, 04 May 2021: Mogrify Limited (Mogrify^®), a biopharmaceutical company aiming to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies, announced today the second closing of its Series A financing of $17 million USD, bringing the total raised to $33 million USD in this round.

April 2021 People Pathways

Click here to view the April 2021 edition of People Pathways.

Biotinylated Heparan Sulfate Antibodies

AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost.

Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC

Cleveland, UK, 29th April 2021 / Sciad Newswire / Leading UK peptide and antibody producers, Cambridge Research Biochemicals (CRB) have today signed a new distribution agreement with Fluoroprobes, LLC (FPL) and Click Chemistry Tools (CCT) to add FPL and CCT’s generic fluorescent activated dyes and click chemistry enabled click-reactive dyes to their existing service portfolio.

Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast Cancer

Research Triangle Park, NC, USA, Cambridge, UK, Irvine, Calif., and Amsterdam – 28 April 2021 – Inivata, a leader in liquid biopsy, today announced it has entered a commercialization agreement with Agendia, Inc., a leader in precision oncology for breast cancer.

Sygnature Discovery expands US presence with office in Bay Area biotech hub

NOTTINGHAM, UK – 27 April, 2021 – Life Science Newswire – Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has established a new office presence in South San Francisco’s biotech hub at Oyster Point, where it can better serve current and future clients on the US west coast.

My Account